Eswatini vs Togo: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Eswatini
90.0%
in 2025
Togo
89.0%
in 2025
Eswatini rank
68th
Togo rank
70th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Eswatini
- Togo
How they compare
Eswatini currently reports 90.0% against 89.0% in Togo, a difference of 1.0%.
The two have swapped places 5 times across 18 shared years of data; in 2008 it was Togo ahead.
Eswatini ranks 68th and Togo ranks 70th of 192 countries.
Across the 3 decades both report, Eswatini averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Eswatini | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 50.9% | 43.9% | 7.0% | Eswatini |
| 2020s | 79.3% | 89.0% | 9.7% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Eswatini or Togo?
- Eswatini, at 90.0% against 89.0% in Togo as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Eswatini and Togo?
- 1.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Togo?
- 18 years are reported by both, from 2008 to 2025.
- How do Eswatini and Togo rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eswatini ranks 68th and Togo ranks 70th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.